... Referencias
Switch to Single-Tablet Bictegravir-Lenacapavir From a Complex HIV Regimen (Artistry-1): A Randomised, Open-Label, Phase 3 Clinical Trial — The Lancet
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy — Gilead
...
... Sleep — Mayo Clinic
Myths and Facts About Sleep — Sleep Foundation
Fatigue Is Associated With Worse Cognitive and Everyday Functioning in Older Persons With HIV — AIDS ...
... Referencias
How HIV Is Transmitted — Terrence Higgins Trust
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
Alianza mundial de acciones para eliminar todas las formas de estigma y discriminación relacionadas con el VIH — UNAIDS
¿Cómo se transmite el VIH? ...
¿Se puede contagiar el VIH sin que haya eyaculación?
... Referencias
How HIV Is Transmitted — Terrence Higgins Trust
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
Alianza mundial de acciones para eliminar todas las formas de estigma y discriminación relacionadas con el VIH — UNAIDS
¿Cómo se transmite el VIH? ...
... /fumarato de disoproxilo de tenofovir
Elvitegravir/cobicistat/emtricitabina/fumarato de alafenamida de tenofovir (Genvoya)
Emtricitabina/rilpivirina/fumarato de disoproxilo de tenofovir (Complera)
Abacavir/lamivudina (Epzicom)
Darunavir/cobicistat/emtricitabina/alafenamida de tenofovir (Symtuza)
Bictegravir/emtricitabina/alafenamida de tenofovir (Biktarvy ...
Tratamientos para el VIH
... /fumarato de disoproxilo de tenofovir
Elvitegravir/cobicistat/emtricitabina/fumarato de alafenamida de tenofovir (Genvoya)
Emtricitabina/rilpivirina/fumarato de disoproxilo de tenofovir (Complera)
Abacavir/lamivudina (Epzicom)
Darunavir/cobicistat/emtricitabina/alafenamida de tenofovir (Symtuza)
Bictegravir/emtricitabina/alafenamida de tenofovir (Biktarvy ...
... Treatment, According to European Survey — Aidsmap
Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States — Advances in Therapy
...
... Initiated on Single-Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide in the United States — Current Medical Research and Opinion
HIV-Related Immune Activation May Predict Weight Gain and Exacerbate Complications, Especially in Women — HIV.gov
Weight Changes, Metabolic Syndrome and All-Cause ...
4 causas de aumento de peso con el VIH
... Initiated on Single-Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide in the United States — Current Medical Research and Opinion
HIV-Related Immune Activation May Predict Weight Gain and Exacerbate Complications, Especially in Women — HIV.gov
Weight Changes, Metabolic Syndrome and All-Cause ...
... and Prevention
CD4 Lymphocyte Count — MedLine Plus
HIV Treatment as Prevention — Centers for Disease Control and Prevention
Ways HIV Is Not Transmitted — Centers for Disease Control and Prevention
...
... Algunas ITS comunes que pueden aumentar el riesgo son la gonorrea, la clamidia, la sífilis y el herpes oral.El riesgo también sube si la persona VIH negativa tiene llagas o úlceras en la boca, encías que sangran, o alguna enfermedad que cause irritación o inflamación en la garganta.Por otro lado, si la persona con VIH tiene heridas, infecciones o inflamación ...
... — AIDS Healthcare Foundation
Ways To Stop HIV Stigma and Discrimination — Centers for Disease Control and Prevention
HIV Stigma and Discrimination— Centers for Disease Control and Prevention
Women’s Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa — AIDS and Behavior ...
5 maneras de terminar con el estigma del VIH
... — AIDS Healthcare Foundation
Ways To Stop HIV Stigma and Discrimination — Centers for Disease Control and Prevention
HIV Stigma and Discrimination— Centers for Disease Control and Prevention
Women’s Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa — AIDS and Behavior ...